EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSMAUG00000010063
Gene Symbol: DHCR24
4 Cross references
208 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSMAUG00000012278
Gene Symbol: HMGCR
3 Cross references
270 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSMAUG00000008130
Gene Symbol: PDPK1
4 Cross references
240 Possible Orthologues:

4-Hydroxyphenylpyruvic Acid Dioxygenase

Ensembl ID : ENSMAUG00000020882
Gene Symbol: HPD
1 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S2-Like

Ensembl ID : ENSMAUG00000017530
Gene Symbol: LOC101824459
2 Cross references
158 Possible Orthologues:

40s Ribosomal Protein S21

Ensembl ID : ENSMAUG00000010991
Gene Symbol: LOC101827403
3 Cross references
187 Possible Orthologues:

40s Ribosomal Protein S21

Ensembl ID : ENSMAUG00000008499
Gene Symbol: LOC101830140
3 Cross references
187 Possible Orthologues:

40s Ribosomal Protein S7

Ensembl ID : ENSMAUG00000012178
Gene Symbol: LOC101835445
4 Cross references
165 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSMAUG00000014835
Gene Symbol: NT5E
4 Cross references
247 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c

Ensembl ID : ENSMAUG00000009530
Gene Symbol: HTR2C
1 Cross references
226 Possible Orthologues:

5-Hydroxytryptamine Receptor 1a

Ensembl ID : ENSMAUG00000007970
Gene Symbol: HTR1A
4 Cross references
147 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSMAUG00000006620
Gene Symbol: HTR1B
4 Cross references
245 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).